Skip to content
Use caution Drug recall · FDA · Published July 23, 2013

Teva Recalls Terazosin HCl 10mg Capsules Due to Labeling Error

Teva recalls 6,267 bottles of Terazosin Hydrochloride 10mg capsules because the label incorrectly states 10mg while containing 5mg. Check your lot number.

🇺🇸 FDA recall #D-842-2013DrugTeva Pharmaceuticals ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA, Inc.650 Cathill Rd · Sellersville, PA 18960-1512
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals USA is recalling a specific lot of Terazosin Hydrochloride Capsules because the bottle label declares a strength of 10 mg, but the contents are actually 5 mg capsules. This labeling error affects 6,267 bottles distributed nationwide and in Puerto Rico. The record does not specify any reported injuries or provide a remedy for consumers. Read more at govinfonow.com/recall/46828-teva-pharmaceuticals-usa-inc-recalls-terazosin-hydrochloride-capsules-10-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/46828-teva-pharmaceuticals-usa-inc-recalls-terazosin-hydrochloride-capsules-10-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-842-2013

Cite this page

“Teva Recalls Terazosin HCl 10mg Capsules Due to Labeling Error.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46828-teva-pharmaceuticals-usa-inc-recalls-terazosin-hydrochloride-capsules-10-mg. Based on FDA recall #D-842-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-842-2013%22&limit=1).

Why it’s dangerous

The hazard is a discrepancy between the labeled strength (10 mg) and the actual content (5 mg). Taking less medication than prescribed may result in inadequate treatment for the condition Terazosin is used to manage, such as high blood pressure or urinary retention. The record does not describe specific injury mechanisms beyond this dosage mismatch.

Who’s affected

Patients who have been prescribed Terazosin Hydrochloride 10 mg capsules from Teva Pharmaceuticals USA, specifically those with lot number N07321 and expiration date 6/14. Individuals in the United States and Puerto Rico who purchased these bottles are at risk of receiving the incorrect dosage.

How to tell if you have this one

Check your bottle for the brand Teva Pharmaceuticals USA and the product name Terazosin Hydrochloride Capsules, 10 mg. Verify that the NDC is 0093-4339-01, the lot number is N07321, and the expiration date is 6/14. The bottles are 100-count sizes.

  • Brand
    Teva Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your bottle details

    Verify if your bottle matches the recalled lot number N07321 and expiration date 6/14.

  2. Contact your pharmacy or doctor

    Since no remedy is stated in the record, consult your healthcare provider for guidance on how to proceed with this specific lot.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Jul 23, 201312. FDA classified it Class II: Aug 6, 201323. Published in FDA’s Enforcement Report: Aug 14, 201334. FDA terminated the recall: Aug 27, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Teva Pharmaceuticals recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-842-2013 (July 23, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-842-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA